Drug shortage
Cyclopentolate Hydrochloride Ophthalmic Solution · Bausch & Lomb Incorporated
FDA drug shortage · Resolved · updated Feb 24, 2025
Key facts
| Generic name | Cyclopentolate Hydrochloride Ophthalmic Solution |
|---|---|
| Proprietary name | Pentolair |
| Company | Bausch & Lomb Incorporated |
| Presentation | Pentolair, Ophthalmic Solution, 10 mg/1 mL (NDC 24208-735-01) |
| Dosage form | Ophthalmic Solution |
| Strength | 10 mg/1 mL |
| Status | Resolved |
| Therapeutic category | Ophthalmology |
| Package NDCs | 24208-735-01 |
| First posted | Nov 9, 2020 |
| Last updated | Feb 24, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: